An independent guide to cash-pay care. Every price is dated and sourced.

How we check

Willow review: cost, pharmacy and complaints

In a decision released Dec 4 2025, the National Advertising Division found that Willow's safety, efficacy and superiority claims for its compounded semaglutide tablets and "Semaglutide Plus" were not supported, and when Willow refused to change them, NAD referred the case to regulators and ad platforms [1]. We rate Willow Caution, provisionally: we found no FDA letter, but we could not confirm its website, prices or pharmacy.

Medical review: pending. A licensed clinician has not yet reviewed this page.

Willow (Willow Health Services, Inc.) is a telehealth company that has marketed compounded semaglutide tablets and a compounded "Semaglutide Plus" injection for weight loss.

Our verdict

Use caution

No FDA letter found, but an advertising watchdog found Willow's claims for its compounded semaglutide unsupported, and Willow refused to comply. Prices, pharmacy and refund terms could not be confirmed.

FDA record
No warning letter found in fda.gov searches or a compilation of 163 letters through Sept 30 2026 [2].
BBB
No confirmed BBB record. We could not check Willow's BBB profile as of Oct 17 2026, so this rating does not rest on a good BBB record and stays provisional until we do. Separately, BBB National Programs' NAD referred Willow's advertising to regulators after it declined to comply (Case #7488) [1].
Best for
Hard to say until prices and terms can be confirmed. Anyone who wants a GLP-1 pill has FDA-approved options.
Watch out
We have not yet confirmed this company's BBB record. NAD found Willow's claims for compounded semaglutide tablets unsupported and said the efficacy claims leaned on studies of brand drugs; Willow refused to change them [1].

Compare online GLP-1 programs

Price
Not confirmed as of Oct 17 2026
Sells
Compounded semaglutide tablets and "Semaglutide Plus" injection, per the NAD case [1]
Pharmacy
Not confirmed
FDA letter
None found [2]
Ad watchdog
NAD Case #7488, Dec 4 2025: claims unsupported; referred to regulators [1]
BBB
No confirmed record; not checked as of Oct 17 2026

What Willow costs

We could not confirm Willow's prices, or even its official website. When we tried to read its site on Oct 17 2026, the request was refused by a rate limit. We will not quote prices we cannot trace to the company.

If you are quoted a price, compare it with what FDA-approved GLP-1 pills cost direct from the makers. NovoCare lists the Wegovy pill at $149 a month for 1.5 mg, $199 for 4 mg and $299 for 9 mg and 25 mg [3]. LillyDirect lists Foundayo at $149 to $299 a month by dose [4]. See Wegovy pill cost, Foundayo and Foundayo vs Wegovy pill.

What Willow sells

The NAD case describes two products: compounded "Semaglutide Tablets" and a compounded "Semaglutide Plus" injection [1]. Both are compounded. Neither is FDA-approved, and FDA does not review compounded drugs for safety, effectiveness or quality [5]. The only FDA-approved semaglutide tablet for weight loss is the Wegovy pill [6]. Our compounded semaglutide guide explains the difference.

The NAD case, step by step

  1. Novo Nordisk, which makes Wegovy and Ozempic, challenged Willow's advertising before the National Advertising Division of BBB National Programs [1].
  2. NAD reviewed Willow's superiority, safety and efficacy claims for its compounded semaglutide tablets and "Semaglutide Plus" and found them unsupported. It recommended Willow stop or change them [1].
  3. Willow's efficacy claims for the compounded tablets relied on studies of brand-name drugs, not of its own product [1].
  4. Willow declined to comply. NAD said it would refer the matter to state attorneys general, federal regulators and ad platforms (decision released Dec 4 2025) [1].

The referral sends the case to state attorneys general, federal regulators and ad platforms [1]. We do not know whether any of them has acted. We found no FDA warning letter to Willow [2]; the companies that did get one are in our FDA warning letter tracker.

Why Caution and not Clean

Strictly, none of our standard triggers is confirmed for Willow: no FDA letter was found and its BBB record is not yet checked. We set Caution because a watchdog found its drug claims unsupported and Willow refused to fix them. Our rating rules explain the triggers. This page stays marked unconfirmed until we can check prices and terms.

Who it fits, who should skip it

If you want a GLP-1 you swallow rather than inject, the approved Wegovy pill and Foundayo have published prices and FDA-reviewed labels. If you want compounded semaglutide by injection, the programs listed next publish prices we could check, though none has a confirmed BBB record yet. Either way, ask any program to show the evidence for its own product, not for a brand drug.

Semaglutide safety

The Wegovy label has a boxed warning for thyroid C-cell tumors seen in rodents and is not for people with a personal or family history of medullary thyroid carcinoma or MEN 2. Its warnings include acute pancreatitis, so severe stomach pain that will not go away needs prompt care, and low blood sugar with insulin or a sulfonylurea [6]. FDA's concerns page covers risks of unapproved GLP-1s [5]. Call 911 for a severe allergic reaction.

Alternatives with published prices

Rated Clean or Caution. See our Ro review for brand pills, or online GLP-1 programs compared for everything else.

We may earn a commission if you sign up through some links on this page. It never changes a verdict. How we make money

Clean or caution alternatives

  1. Price
    Membership $39 first month, then $74 to $149/mo; Wegovy pill from $149/mo; Zepbound KwikPen $299 to $449/mo (checked Oct 17 2026) [7]
    What you get
    FDA-approved brand GLP-1s only (Wegovy pen and pill, Zepbound, Foundayo)
    FDA record
    No warning letter found
    BBB
    Not yet confirmed
    Note
    Membership is billed on top of the drug. See our Ro review.

    Visit Ro (Ro Body Program)

  2. LifeMD

    Clean
    Price
    Program $39 first month, then $149/mo, plus medication: Wegovy pill from $149/mo, Zepbound vial from $299/mo (checked Oct 17 2026) [8]
    What you get
    Brand-name GLP-1s with insurance help
    FDA record
    No warning letter found
    BBB
    Not yet confirmed
    Note
    Program fee is separate from the drug. See our LifeMD review.

    Visit LifeMD

  3. Found

    Clean
    Price
    Compounded semaglutide plan $169 to $289 per 28 days cash, medication included (checked Oct 17 2026) [9]
    What you get
    Compounded and brand GLP-1s plus non-GLP-1 options
    FDA record
    No warning letter found
    BBB
    Not yet confirmed
    Note
    Bills every 28 days, so 13 charges a year. See our Found review.

    Visit Found

  4. Direct Meds

    Use caution
    Price
    Compounded semaglutide $297/mo; compounded tirzepatide $399/mo, all-inclusive (checked Oct 17 2026) [10]
    What you get
    Compounded semaglutide and tirzepatide
    FDA record
    Warning letter Sept 9 2025; cited claims not found on its main pages Oct 17 2026 [11]
    BBB
    Not yet confirmed
    Note
    Caution rating. See our Direct Meds review.

    Visit Direct Meds

Compare online GLP-1 programs

Questions people ask

Is Willow weight loss legit?

Willow Health Services, Inc. is a real telehealth company with no FDA warning letter that we found [2]. In a Dec 4 2025 decision, NAD found its claims for compounded semaglutide unsupported and referred it to regulators after Willow refused to comply [1]. We rate it Caution, provisionally.

How much does Willow cost?

We could not confirm Willow's prices as of Oct 17 2026. For comparison, the FDA-approved Wegovy pill costs $149 to $299 a month by dose through NovoCare [3].

What is Willow Semaglutide Plus?

A compounded semaglutide injection Willow marketed, named in NAD Case #7488. NAD found Willow's safety, efficacy and superiority claims for it unsupported [1]. Compounded semaglutide is not FDA-approved [5].

Are Willow's semaglutide tablets FDA-approved?

No. They are compounded. The only FDA-approved semaglutide tablet for weight loss is the Wegovy pill [6]. NAD said Willow's efficacy claims for its tablets relied on brand-drug studies [1].

What is the NAD and why does its decision matter?

The National Advertising Division of BBB National Programs reviews whether ad claims are supported. In Willow's case it found the claims unsupported, and when Willow refused to comply it referred the case to state attorneys general, federal regulators and ad platforms [1].

What pharmacy does Willow use?

We could not confirm it. Ask before paying. FDA says telehealth firms should not imply they make compounded drugs or that a pharmacy is FDA-approved [12].

Sources

12 cited
  1. NAD decision: Willow Health Services, Inc. (Case #7488). BBB National Programs, Dec 4, 2025.
  2. FDA warning letters database (compilation of fda.gov letters). WeightLossRankings.org, Sep 30, 2026.
  3. Wegovy self-pay offer. Novo Nordisk (NovoCare Pharmacy), Oct 17, 2026.
  4. Foundayo self-pay prices. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
  5. FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration, Oct 1, 2026.
  6. Wegovy (semaglutide) label. DailyMed, National Library of Medicine, Jun 2026.
  7. Ro weight loss pricing. Ro, Oct 17, 2026.
  8. LifeMD weight management program and prices. LifeMD, Inc., Oct 17, 2026.
  9. Found offer terms (v3). Found Health, Inc., Oct 17, 2026.
  10. DirectMeds pricing. DirectMeds, Oct 17, 2026.
  11. FDA warning letter: directmeds.com, Inc. dba DirectMeds (716822). U.S. Food and Drug Administration, Sep 9, 2025.
  12. FDA: what telehealth companies should know when promoting compounded drugs. U.S. Food and Drug Administration, Jun 15, 2026.

This page is general information, not medical advice. Talk with a licensed clinician about your own care.

Compare online GLP-1 programs